Aromatase inhibitors vs tamoxifen (indirect comparison)a
Overall breast cancer incidence · women with above‐average risk of developing breast cancer
Aromatase inhibitors may leads to lower overall breast cancer incidence compared with tamoxifen (indirect comparison)a (low certainty).
1 finding from 1 review
- Risk‐reducing medications for primary breast cancer: a network meta‐analysis 2019 · Cochrane Headline outcomes onlyRR 0.67 [0.46, 0.98]5 studies · 31256 participantsLow